Grant-Huerta Yanina Insider Trading Activity

Corporate InsiderChief Accounting Officer · CIK 2064348

11

Total trades

$78K

Total volume

May 18, 2026

Last activity

ATRA

Atara Biotherapeutics, Inc.

Grant-Huerta Yanina has been net-selling over the last 12 months with 0 purchases and 11 sales across 1 company.

ATRA is the most-traded position with 11 trades. The largest single transaction was a sale of ATRA for $22K on May 18, 2026.

Performance Scorecard

Forward stock performance after each transaction by Grant-Huerta Yanina. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days-9.7%30%10
90 days-19.9%30%10
120 days+4.5%50%6

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

ATRA · Atara Biotherapeutics, Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when Grant-Huerta Yanina bought and sold ATRA.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEROLE
May 18, 2026ATRASell2,414$9.13$22KChief Accounting Officer
Mar 2, 2026ATRASell24$5.08$121.848Chief Accounting Officer
Mar 2, 2026ATRASell1,603$5.08$8KChief Accounting Officer
Mar 2, 2026ATRASell377$5.08$2KChief Accounting Officer
Mar 2, 2026ATRASell100$5.08$508.3Chief Accounting Officer
Nov 17, 2025ATRASell1,645$13.19$22KChief Accounting Officer
Nov 17, 2025ATRASell85$13.19$1KChief Accounting Officer
Nov 17, 2025ATRASell74$13.19$976.134Chief Accounting Officer
Aug 18, 2025ATRASell55$11.61$638.495Chief Accounting Officer
Aug 18, 2025ATRASell86$11.61$998.718Chief Accounting Officer
Aug 18, 2025ATRASell1,668$11.61$19KChief Accounting Officer

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
ATRAAtara Biotherapeutics, Inc.11$78K

Other insiders at Atara Biotherapeutics, Inc.

2 other tracked filers at ATRA.